Shenghe Biotech-B (02898.HK) received resumption guidance from the Stock Exchange and will continue to suspend trading.

Intelligence Wealth Financial APP news, Shenghe Bio-B (02898.HK) announced that on April 30, 2026, the company received a letter from the Hong Kong Stock Exchange, which contains guidelines on the resumption of trading of the stock.